Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy (semaglutide) should not be injected straight from the fridge. The medicine itself stays stable at refrigerator temperature, but injecting cold liquid subcutaneously is more likely to sting and can cause temporary discomfort at the injection site. The Patient Information Leaflet recommends letting the pen reach room temperature before use. As a prescription-only medicine, Wegovy is prescribed after a clinical assessment, and your prescriber or pharmacist is always the right person to confirm storage questions specific to your situation. That said, here is what the clinical and regulatory evidence actually says about temperature, storage and injection comfort.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The semaglutide Patient Information Leaflet, published on the electronic Medicines Compendium, is clear: store Wegovy pens in the fridge at 2–8°C, away from the freezer and any cooling element. Once a pen is removed from refrigeration, it can be kept at room temperature (below 30°C) for a maximum of 28 days. Inject within that window or discard. The leaflet does not state that you must warm the pen before injecting, but the practical advice from clinical teams is consistent: cold liquid injected into subcutaneous tissue is more likely to cause stinging, temporary discomfort or localised redness at the site. None of those effects alter how semaglutide is absorbed. They are a comfort issue, not a pharmacological one.
The NHS medicines guidance for semaglutide notes that injection-site reactions (including redness, bruising and irritation) are among the more commonly reported effects of weekly semaglutide injections. Keeping the pen closer to room temperature before use is one of the straightforward steps that can reduce that particular nuisance. For the precise storage window and any updated instructions, always read your own pen's leaflet; it is the authoritative source for your specific product batch.
If you have questions about whether Wegovy should be injected cold in your own circumstances, your prescriber is the right person to ask at your next review.
A question that comes up more than you might expect: does injecting Wegovy cold make it work less well, or waste the dose? The short answer is no. Semaglutide's efficacy is not meaningfully altered by a few degrees of temperature variation at the point of injection. The STEP 1 trial (published in the New England Journal of Medicine) established that weekly semaglutide 2.4mg produced roughly 15% average weight loss over 68 weeks compared with placebo. That result came from a controlled clinical environment with standardised pen handling, but the medicine's absorption profile does not depend on the pen being at any particular temperature at the moment of injection. What cold temperature affects is the experience of injecting, not the outcome.
Throwing away a dose because you forgot to take it out of the fridge in time would be far more consequential than the slight discomfort of injecting it cool. If you are pressed for time, a 10–15 minute rest at room temperature is usually enough to take the chill off. Avoid using hot water or a microwave to speed this up; rapid heating risks damaging the medicine.
Technique matters too. The ways Wegovy can be injected incorrectly cover a broader range of steps (site selection, pinching the skin, needle insertion angle) and all of them are worth reviewing if you are new to self-injection.
Wegovy can be injected into the abdomen, outer thigh or upper arm. Each site has slightly different tissue characteristics: abdominal fat tends to be the most forgiving for subcutaneous injection, while the outer thigh and upper arm can feel more sensitive, particularly when the medicine is cold. If you find one site more uncomfortable than others, rotating to a warmer site (and letting the pen reach room temperature first) often makes the difference. The upper arm as a Wegovy injection site is licensed and used routinely, but for some people it is the site where temperature matters most.
A site that has been recently injected, bruised or otherwise irritated should be avoided regardless of temperature. Rotating injection sites (not returning to the same spot for at least a few weeks) is standard guidance. The gluteal region as an injection site is also an option some people find comfortable, though it requires a bit more flexibility to reach safely. Clean the chosen area with an alcohol swab beforehand; individually wrapped swabs are a practical addition to any weekly injection routine.
If you are away from home and keeping your pen cool while travelling, the 28-day room-temperature window is useful to understand. The page on keeping Wegovy cold when travelling covers insulated cases and other practical options in more detail.
If you forget to take the pen out in advance and inject it cold, the practical steps are simple: note any localised redness or stinging, apply gentle pressure to the site if needed, and carry on. You do not need to repeat the injection. The dose has been delivered. The NHS guidance on semaglutide describes injection-site reactions as common and usually mild; occasional temperature-related discomfort sits in the same category.
If you notice persistent swelling, a lump that does not resolve within a few days, or any signs of an allergic reaction (hives, breathing difficulty, rapid heartbeat) that warrants urgent medical attention and is unrelated to temperature. Report unexpected side effects via the MHRA Yellow Card scheme, which allows patients to flag suspected reactions directly to the regulator.
Wegovy is a prescription medicine that needs clinical oversight at every stage, from the initial assessment through to dose reviews. If you are thinking about starting treatment or are already on it and have questions, our full Wegovy overview covers eligibility and what to expect. For a broader look at weight-loss treatment options, including how private and NHS routes differ, that page sets out the landscape plainly. And if cost is a consideration, the Wegovy pricing page explains what a private prescription typically involves without any numbers buried in the small print.
When you are ready to find out whether Wegovy is clinically suitable for you, check your eligibility with our prescribers — there is no charge for the consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.